An interventional study of stretching and active movement training in Acute Stroke, sponsored by University of Maryland, Baltimore. Recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-04-21.
Sponsored by University of Maryland, Baltimore · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Stroke by University of Maryland, Baltimore — 7 open to participants now, 7 under way, none of them phase 3. Stroke · University of Maryland, Baltimore.
Among the 13 studies in Stroke by University of Maryland, Baltimore, this one has the largest planned enrollment of the 11 interventional ones that give a count, is one of 3 that started in 2019, is one of 9 with no phase, and was the 3rd registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →7 of the 13 studies in Stroke by University of Maryland, Baltimore are open now, in 1 country. Recruiting first, the newest first:
University of Maryland, Baltimore · Sites in United States
Ages 30–85
University of Maryland, Baltimore · Sites in United States
Ages 18–85
University of Maryland, Baltimore · Sites in United States
Ages 18–85
University of Maryland, Baltimore · Sites in United States
Ages 18–85 · Healthy volunteers
University of Maryland, Baltimore · Sites in United States
Ages 18–88
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 3 started in 2019.
This study's planned enrollment of 140 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 32 across the 11 interventional studies, 15,271 across the 2 observational. Of the 6 that completed or were terminated, 1 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Maryland, Baltimore is the lead sponsor of 700 studies on the registry; 131 are open to participants now.
Of its 92 completed or terminated interventional studies of FDA-regulated products, 66 (72%) have results posted.
3 of the studies in Stroke by University of Maryland, Baltimore that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02359812University of Maryland, BaltimoreRobot Aided Rehabilitation - Multi-joint Evaluations | 2027-05-31 |
| NCT07804342University of Maryland, BaltimoreAnkle Robotics for Error Augmentation After Stroke | 2027-07 |
| NCT04550728University of Maryland, BaltimoreHybrid Robot+FES Stroke Rehabilitation | 2027-10-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 13 studies in Stroke by University of Maryland, Baltimore, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Early after stroke, patients often have significant motor impairment and sensory deficit. Evidence has demonstrated heightened plasticity and significant recovery in the acute phase (first months) post stroke but there has been a lack of effective and practical protocols and devices for early intensive sensorimotor therapy.This research study will conduct a randomized clinical trial of an intensive motor-sensory rehabilitation on patients with acute stroke using a wearable rehabilitation robot. The primary aims are to facilitate sensorimotor recovery, reduce ankle impairments, and improve balance and gait functions. This clinical trial will be conducted on the Study and Control groups of acute stroke survivors.
The study will investigate an early intensive rehabilitation in acute stroke for motor relearning, reducing ankle impairments and improving balance and mobility/locomotion functions.
The acute stroke survivor will be randomly placed into two groups. Subjects in the Study group will receive robot-aided motor relearning under real-time feedback, stretching under intelligent control, sensory stimulation, and active movement training with interactive games. Subjects in the Control group will receive passive movement in the middle ROM without intelligent stretching and active movement training without robotic guidance.
For both groups, the therapeutic training will be conducted during 5 hourly sessions (including breaks/transitions between tasks) each week over about 3-week hospital stay. Both groups will also receive the standard of care in the hospital and rehabilitation service. Treatment outcome measures will be obtained through blinded assessments and evaluated before and after training involving biomechanical, neuromuscular and clinical outcome measures. Carry-over effects will be further evaluated 1 month after the treatment ends.
Aim 1: To evaluate biomechanical and neuromuscular changes as defined by the passive and active range of motion (ROM), flexor-extensor muscle strength, joint stiffness, proprioception and reflex excitability, and compare these measures between the two groups. The biomechanical and neuromuscular outcome measures will be obtained through blinded assessments and evaluated before and after training using the wearable rehabilitation robot.
Hypothesis 1: Robot-guided motor relearning, stretching and active movement training (Study group) will improve the biomechanical and neuromuscular outcome measures more than those of the Control group.
Aim 2: To evaluate the clinical outcome measures as defined by Fugl-Meyer score (lower extremity), modified Ashworth scale, Berg balance scale, 10 meter walk test, and to compare between the Study and Control groups.
Hypothesis 2: The Study group will improve the clinical outcome measures more than the Control group.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Subjects in the Study group will receive stretching and active movement training with robotic guidance and intelligent control
Device: stretching and active movement training
Subjects in the Control group will receive stretching and active movement training without robotic guidance.
Device: stretching and active movement training
A portable rehabilitation robot will be used to strongly or gently move the impaired ankle joint back and forth. Then subjects will be asked to use muscles to move the ankle with or without the robotic guidance depending on which group the subjects are in.
Changes of Fugl-Meyer Lower Extremity (FMLE)
The assessment is a measure of lower extremity (LE) motor and sensory impairments.
Time frame: At the beginning and end of 3-week training, and 1 month after the treatment ends
Changes of active range of motion (AROM)
AROM will be measured in degrees in the ankle joint while subjects use the muscles to move the ankle.
Time frame: At the beginning and end of 3-week training, and 1 month after the treatment ends
Changes of passive range of motion (PROM)
PROM will be measured in degrees in the ankle joint while the robot moves the ankle of the subject strongly.
Time frame: At the beginning and end of 3-week training, and 1 month after the treatment ends
Changes of ankle strength
Strength of the ankle flexor-extensor muscle will be measured in Newton
Time frame: At the beginning and end of 3-week training, and 1 month after the treatment ends
Changes of ankle stiffness
Spasticity will be measured by the resistance torque in Newton-meter under controlled movement at each joint.
Time frame: At the beginning and end of 3-week training, and 1 month after the treatment ends
Changes of Modified Ashworth Scale (MAS)
The Modified Ashworth Scale is the most widely used assessment tool to measure resistance to limb movement in a clinic setting. Scores range from 0-4, with 6 choices. 0 (0) - No increase in muscle tone; 1 (1) - Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension; 1+ (2) - Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM (range of movement); 2 (3) - More marked increase in muscle tone through most of the ROM, but affect part(s) easily moved; 3 (4) - Considerable increase in muscle tone passive, movement difficult; 4 (5) - Affected part(s) rigid in flexion or extension.
Time frame: At the beginning and end of 3-week training, and 1 month after the treatment ends
Changes of Berg Balance Scale
The Berg balance scale is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete.
Time frame: At the beginning and end of 3-week training, and 1 month after the treatment ends
Changes of 10 meter Walk Test
The 10 Metre Walk Test is a performance measure used to assess walking speed in metres per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function.
Time frame: At the beginning and end of 3-week training, and 1 month after the treatment ends
Plan to share: No
Started Apr 2019 (actual). Primary completion is estimated for Dec 2027, 104 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 104 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Maryland, Baltimore →